Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Platform Trial, Evaluating New Drugs or Combination in Relapsed or Refractory Peripheral T-cell Lymphomas

NCT07018752 is registered in ClinicalTrials.gov with The Lymphoma Academic Research Organisation as lead sponsor.

NCT NCT07018752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07018752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Platform Trial, Evaluating New Drugs or Combination in Relapsed or Refractory Peripheral T-cell Lymphomas
Lead sponsor
The Lymphoma Academic Research Organisation
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 20, 2025
Completion date
January 31, 2030
Enrollment
49 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t cells lymphoma (ptcl)